✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹8,362 Cr.
P/E
0.00
About
Chemplast Sanmar Limited, an India-based specialty chemicals manufacturer, primarily focuses on specialty paste PVC resin production and custom manufacturing of starting materials and intermediates fo… Read more
Chemplast Sanmar Limited, an India-based specialty chemicals manufacturer, primarily focuses o… Read more
Low
403
52W Range
High
634
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Custom financial statement
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share
80 %
(as of Mar 23)
PVC Resin - Capacity Market Share
2 %
(as of Mar 19)
Polymers - Capacity Market Share
Revenue mix

Segment Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up - Segment Wise

Operational Metrics

    Select a Metric
    • Realization / Tonne - Chemicals (Rs/MT)
    • Quarterly Sales Volume - Chemicals (Tonnes)
    Peer Comparison
    FAQs on Chemplast Sanmar Ltd. Business

    Chemplast Sanmar, a specialty chemicals manufacturer in India, specializes in paste PVC resin and custom manufacturing. They also produce Caustic Soda, Chlorochemicals, and more.

    Chemplast Sanmar major competitors are Laxmi Organic Inds., Archean Chem Inds, GHCL, NOCIL, Grauer & Weil (I), Neogen Chemicals, Jubilant Ingrevia.
    Market Cap of Chemplast Sanmar is ₹8,146 Crs.
    While the median market cap of its peers are ₹6,588 Crs.

    Chemplast Sanmar seems to be less financially stable compared to its competitors.
    Altman Z score of Chemplast Sanmar is 1.9 and is ranked 8 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Sep Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis